Kojiro M - Search Results

1

Effect of vitamin K2 on the recurrence of hepatocellular carcinoma.

Yoshida H, Shiratori Y, Kudo M, Shiina S, Mizuta T, Kojiro M, Yamamoto K, Koike Y, Saito K, Koyanagi N, Kawabe T, Kawazoe S, Kobashi H, Kasugai H, Osaki Y, Araki Y, Izumi N, Oka H, Tsuji K, Toyota J, Seki T, Osawa T, Masaki N, Ichinose M, Seike M, Ishikawa A, Ueno Y, Tagawa K, Kuromatsu R, Sakisaka S, Ikeda H, Kuroda H, Kokuryu H, Yamashita T, Sakaida I, Katamoto T, Kikuchi K, Nomoto M, Omata M. Yoshida H, et al. Among authors: kojiro m. Hepatology. 2011 Aug;54(2):532-40. doi: 10.1002/hep.24430. Epub 2011 Jun 26. Hepatology. 2011. PMID: 21574174 Clinical Trial.

2

Microvascular invasion in patients with hepatocellular carcinoma and its predictable clinicopathological factors.

Sumie S, Kuromatsu R, Okuda K, Ando E, Takata A, Fukushima N, Watanabe Y, Kojiro M, Sata M. Sumie S, et al. Among authors: kojiro m. Ann Surg Oncol. 2008 May;15(5):1375-82. doi: 10.1245/s10434-008-9846-9. Epub 2008 Mar 7. Ann Surg Oncol. 2008. PMID: 18324443

3

Surgical resection vs. percutaneous ablation for hepatocellular carcinoma: a preliminary report of the Japanese nationwide survey.

Hasegawa K, Makuuchi M, Takayama T, Kokudo N, Arii S, Okazaki M, Okita K, Omata M, Kudo M, Kojiro M, Nakanuma Y, Takayasu K, Monden M, Matsuyama Y, Ikai I. Hasegawa K, et al. Among authors: kojiro m. J Hepatol. 2008 Oct;49(4):589-94. doi: 10.1016/j.jhep.2008.05.018. Epub 2008 Jun 12. J Hepatol. 2008. PMID: 18620773

4

Management of hepatocellular carcinoma in Japan: Consensus-Based Clinical Practice Guidelines proposed by the Japan Society of Hepatology (JSH) 2010 updated version.

Kudo M, Izumi N, Kokudo N, Matsui O, Sakamoto M, Nakashima O, Kojiro M, Makuuchi M; HCC Expert Panel of Japan Society of Hepatology. Kudo M, et al. Among authors: kojiro m. Dig Dis. 2011;29(3):339-64. doi: 10.1159/000327577. Epub 2011 Aug 9. Dig Dis. 2011. PMID: 21829027

5

Diagnostic accuracy of imaging for liver cirrhosis compared to histologically proven liver cirrhosis. A multicenter collaborative study.

Kudo M, Zheng RQ, Kim SR, Okabe Y, Osaki Y, Iijima H, Itani T, Kasugai H, Kanematsu M, Ito K, Usuki N, Shimamatsu K, Kage M, Kojiro M. Kudo M, et al. Among authors: kojiro m. Intervirology. 2008;51 Suppl 1:17-26. doi: 10.1159/000122595. Epub 2008 Jun 10. Intervirology. 2008. PMID: 18544944

6

Reevaluation of prognostic factors for survival after liver resection in patients with hepatocellular carcinoma in a Japanese nationwide survey.

Ikai I, Arii S, Kojiro M, Ichida T, Makuuchi M, Matsuyama Y, Nakanuma Y, Okita K, Omata M, Takayasu K, Yamaoka Y. Ikai I, et al. Among authors: kojiro m. Cancer. 2004 Aug 15;101(4):796-802. doi: 10.1002/cncr.20426. Cancer. 2004. PMID: 15305412 Free article.

7

Immunohistologic study on the expressions of alpha-fetoprotein and protein induced by vitamin K absence or antagonist II in surgically resected small hepatocellular carcinoma.

Fujioka M, Nakashima Y, Nakashima O, Kojiro M. Fujioka M, et al. Among authors: kojiro m. Hepatology. 2001 Dec;34(6):1128-34. doi: 10.1053/jhep.2001.29202. Hepatology. 2001. PMID: 11732002

8

Expression of cyclooxygenase-2 in human hepatocellular carcinoma: relevance to tumor dedifferentiation.

Koga H, Sakisaka S, Ohishi M, Kawaguchi T, Taniguchi E, Sasatomi K, Harada M, Kusaba T, Tanaka M, Kimura R, Nakashima Y, Nakashima O, Kojiro M, Kurohiji T, Sata M. Koga H, et al. Among authors: kojiro m. Hepatology. 1999 Mar;29(3):688-96. doi: 10.1002/hep.510290355. Hepatology. 1999. PMID: 10051469

9

Value of fusing PET plus CT images in hepatocellular carcinoma and combined hepatocellular and cholangiocarcinoma patients with extrahepatic metastases: preliminary findings.

Nagaoka S, Itano S, Ishibashi M, Torimura T, Baba K, Akiyoshi J, Kurogi J, Matsugaki S, Inoue K, Tajiri N, Takada A, Ando E, Kuromatsu R, Kaida H, Kurogi M, Koga H, Kumashiro R, Hayabuchi N, Kojiro M, Sata M. Nagaoka S, et al. Among authors: kojiro m. Liver Int. 2006 Sep;26(7):781-8. doi: 10.1111/j.1478-3231.2006.01296.x. Liver Int. 2006. PMID: 16911459

10

Significance of glucose intolerance and SHIP2 expression in hepatocellular carcinoma patients with HCV infection.

Sumie S, Kawaguchi T, Komuta M, Kuromatsu R, Itano S, Okuda K, Taniguchi E, Ando E, Takata A, Fukushima N, Koga H, Torimura T, Kojiro M, Sata M. Sumie S, et al. Among authors: kojiro m. Oncol Rep. 2007 Sep;18(3):545-52. Oncol Rep. 2007. PMID: 17671700

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

326 results

Search Page

Filters